Induced Pluripotent Stem Cell Derived Cardiomyocytes
Powered by Axiogenesis
Sigma® Life Science is proud to be the global distributor of Axiogenesis murine stem cell derived cell products and drug screening service portfolio. Derived cell types include physiologically relevant cardiomyocytes and smooth muscle cells. Axiogenesis is a leader in mouse pluripotent stem cell derived cardiomyocytes. Together Sigma Life Science and Axiogenesis will provide iPS-cell derived primary-cell-like cardiomyocytes that are more predictive of clinical outcomes for drug discovery and toxicology studies. Cor.At™ cardiomyocytes are extensively characterized and application tested.
Isolation of primary cardiomyocytes are labor intensive and often lack consistency and purity. Sigma Life Science iPSC derived cardiomyocyte products, powered by Axiogenesis, are a consistent and convenient source of large numbers of physiologically relevant cardiomyocytes validated for functional electrophysiology, calcium-flux and calcium-wave analysis, cardiac cytotoxicty, mitochondrial metabolism, and disease model for cardiac hypertrophy.
Cor.At miPSC derived cardiomyocytes are a physiologically relevant model for cardiac toxicity. Derived cell types will be available as off-the-shelf cells, application specific kits and custom services to satisfy the wide range of research needs.
Pure Cor.At cardiomyocytes
Smooth muscle cells derived from mouse ES Cells available now
Custom screening services offered
To discuss your cardiac toxicity needs or pricing for services please send inquires to firstname.lastname@example.org.